Rare diseases
Investigational molecules
Locations
Back to Greece11 clinical trials in Chios, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GreeceRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
GreeceStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
GreeceStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GreeceStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
GreeceGreeceStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
GreeceA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
GreeceEvaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
GreeceA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
GreeceA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
GreeceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on perioperative atrial fibrillation management following non-cardiac surgical procedures. Researchers are evaluating novel anticoagulation strategies for stroke prevention in post-surgical patients.
This research aims to enhance understanding of vascular outcomes and optimize treatment approaches for patients experiencing atrial fibrillation after surgery, with particular attention to preventing systemic embolism and reducing mortality rates.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
